Effectiveness, safety, and treatment pattern of sodium zirconium cyclosilicate in Chinese patients with hyperkalemia: interim analysis from a multicenter, prospective, real-world study (Actualize Study) (vol 15, 1398953, 204)

被引：0

作者：

Shen, Nan ^{[1
]}

Zhang, Lihong ^{[2
]}

Yang, Jing ^{[3
]}

Lin, Yongqiang ^{[4
]}

Liu, Xinyu ^{[5
]}

Cai, Xudong ^{[6
]}

Cao, Juan ^{[7
]}

Zhu, Qiang ^{[8
]}

Luo, Xun ^{[9
]}

Wan, Xin ^{[10
]}

Wu, Henglan ^{[11
]}

Ye, Jianming ^{[12
]}

Shan, Chunyan ^{[13
]}

Xie, Hua ^{[14
]}

Wu, Yifan ^{[15
]}

Cao, Yanping ^{[16
]}

Wang, Jianmin ^{[17
]}

Yu, Xiaoyong ^{[18
]}

Wang, Huimin ^{[19
]}

He, Jingdong ^{[20
]}

Tian, Shaojiang ^{[21
]}

Wu, Fenglei ^{[22
]}

Jiang, Xinxin ^{[23
]}

Li, Lu ^{[24
]}

Zuo, Li ^{[25
]}

Wang, Zhaohua ^{[26
]}

Xing, Changying ^{[27
]}

Yin, Xun ^{[28
]}

Zhao, Jianrong ^{[29
]}

Ma, Cong ^{[30
]}

Long, Gang ^{[31
]}

Li, Qing ^{[32
]}

Hu, Yao ^{[33
,34
]}

Shi, Yifan ^{[35
]}

Lin, Hong-Li ^{[1
]}

机构：

[1] Dalian Med Univ, Affiliated Hosp 1, Dalian, Liaoning, Peoples R China

[2] Hebei Med Univ, Hosp 1, Shijiazhuang, Hebei, Peoples R China

[3] Hefei First Peoples Hosp, Huaihe Rd, Hefei, Anhui, Peoples R China

[4] Wenzhou Integrated Chinese & Western Med Hosp, Wenzhou, Zhejiang, Peoples R China

[5] Nanyang Cent Hosp, Nanyang, Henan, Peoples R China

[6] Ningbo Tradit Chinese Med Hosp, Ningbo, Zhejiang, Peoples R China

[7] Taixing Peoples Hosp, Taizhou, Jiangsu, Peoples R China

[8] Xinghua Peoples Hosp, Taizhou, Peoples R China

[9] Hunan Prov Peoples Hosp, Changsha, Hunan, Peoples R China

[10] First Hosp Nanjing, Nanjing, Jiangsu, Peoples R China

[11] First Hosp Jiaxing, Jiaxing, Zhejiang, Peoples R China

[12] First Peoples Hosp Kunshan, Suzhou, Jiangsu, Peoples R China

[13] Tianjin Med Univ, Chu Hsien I Mem Hosp, Tianjin, Peoples R China

[14] Dalian Ruikaer Renal Dis Hosp, Dalian, Liaoning, Peoples R China

[15] Guangdong Prov Hosp Tradit Chinese Med, Guangzhou, Guangdong, Peoples R China

[16] Handan First Hosp, Handan, Hebei, Peoples R China

[17] Linfen Cent Hosp, Linfen, Shanxi, Peoples R China

[18] Shanxi Prov Hosp Tradit Chinese Med, Taiyuan, Shanxi, Peoples R China

[19] Bengang Gen Hosp, Liaoning Hlth Ind Grp, Benxi, Liaoning, Peoples R China

[20] Nucl Ind 416 Hosp, Chengdu, Sichuan, Peoples R China

[21] Shiyan Peoples Hosp, Shiyan, Peoples R China

[22] Nantong Univ, Qidong Peoples Hosp, Qidong Hosp, Nantong, Jiangsu, Peoples R China

[23] Sandun Dist Zhejiang Hosp, Hangzhou, Zhejiang, Peoples R China

[24] Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China

[25] Peking Univ Peoples Hosp, Beijing, Peoples R China

[26] Taian City Cent Hosp, Tai An, Shandong, Peoples R China

[27] Jiangsu Prov Official Hosp, Nanjing, Jiangsu, Peoples R China

[28] Changshu 2 Peoples Hosp, Suzhou, Peoples R China

[29] Inner Mongolia Med Univ, Affiliated Hosp, Hohhot, Inner Mongolia, Peoples R China

[30] Anshan Cent Hosp, Anshan, Liaoning, Peoples R China

[31] Tianjin Peoples Hosp, Tianjin, Peoples R China

[32] Tianjin TEDA Hosp, Tianjin, Peoples R China

[33] Chengdu Univ, Clin Med Coll, Chengdu, Sichuan, Peoples R China

[34] Chengdu Univ, Affiliated Hosp, Chengdu, Sichuan, Peoples R China

[35] AstraZeneca Investment China Co, Med Affairs, Shanghai, Peoples R China

来源：

FRONTIERS IN PHARMACOLOGY | 2024年 / 15卷

关键词：

hyperkalemia; sodium zirconium cyclosilicate; safety; real-world clinical practice; Chinese population;

D O I：

10.3389/fphar.2024.1495716

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页数：2

共 18 条

[1] Effectiveness, safety, and treatment pattern of sodium zirconium cyclosilicate in Chinese patients with hyperkalemia: interim analysis from a multicenter, prospective, real-world study (Actualize Study)
Shen, Nan
Zhang, Lihong
Yang, Jing
Lin, Yongqiang
Liu, Xinyu
Cai, Xudong
Cao, Juan
Zhu, Qiang
Luo, Xun
Wan, Xin
Wu, Henglan
Ye, Jianming
Shan, Chunyan
Xie, Hua
Wu, Yifan
Cao, Yanping
Wang, Jianmin
Yu, Xiaoyong
Wang, Huimin
He, Jingdong
Tian, Shaojiang
Wu, Fenglei
Jiang, Xinxin
Li, Lu
Zuo, Li
Wang, Zhaohua
Xing, Changying
Yin, Xun
Zhao, Jianrong
Ma, Cong
Long, Gang
Li, Qing
Hu, Yao
Shi, Yifan
Lin, Hongli
FRONTIERS IN PHARMACOLOGY, 2024, 15
[2] Real-World Modifications of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Hyperkalemia Initiating Sodium Zirconium Cyclosilicate Therapy: The OPTIMIZE I Study
Agiro, Abiy
Amin, Alpesh N.
Cook, Erin E.
Mu, Fan
Chen, Jingyi
Desai, Pooja
Oluwatosin, Yemmie
Pollack Jr, Charles V.
ADVANCES IN THERAPY, 2023, 40 (06) : 2886 - 2901
[3] Real-World Modifications of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Hyperkalemia Initiating Sodium Zirconium Cyclosilicate Therapy: The OPTIMIZE I Study
Abiy Agiro
Amin AN
Erin E. Cook
Fan Mu
Jingyi Chen
Pooja Desai
Yemmie Oluwatosin
Charles V. Pollack
Advances in Therapy, 2023, 40 : 2886 - 2901
[4] Real-world safety and effectiveness of adalimumab in patients with pyoderma gangrenosum: Interim analysis of a post-marketing observational study in Japan
Yamamoto, Toshiyuki
Yamanaka, Keiichi
Yamasaki, Kenshi
Isaji, Hisaaki
Matsubara, Naoko
Hozawa, Hiroyuki
Kawakami, Tamihiro
JOURNAL OF DERMATOLOGY, 2025, 52 (02) : 270 - 280
[5] Safety and efficacy of generic nab-paclitaxel-based therapy in Chinese patients with malignant tumors in a real-world setting: a multicenter prospective observational study
He, Fei
Sun, Yancai
Zhang, Wenzhou
Wu, Qiongshi
Xu, Donghang
Bai, Zaixian
Hao, Zhiying
Feng, Weiyi
Zhang, Kanghuai
Liu, Jiang
Dong, Mei
Liu, Guangxuan
Li, Guohui
DISCOVER ONCOLOGY, 2024, 15 (01)
[6] Real-world safety of linaclotide in Chinese patients with irritable bowel syndrome with constipation: a multicenter, single-arm, prospective observational study
Xiao, Yinglian
Meng, Xianmei
Luo, Qingfeng
Hou, Xiaohua
Jin, Jie
Zhong, Xianfei
Gong, Wei
Li, Xiuling
Chen, Minhu
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2025, 18
[7] Real-world effectiveness of fremanezumab for the preventive treatment of migraine: Interim analysis of the pan-European, prospective, observational, phase 4 PEARL study
Ashina, Messoud
Mitsikostas, Dimos D.
Amin, Faisal Mohammad
Kokturk, Pinar
Schankin, Christoph J.
Sahin, Gurdal
Pozo-Rosich, Patricia
Dorman, Paul J.
Nezadal, Tomas
Poole, Anne Christine
Martins, Isabel Pavao
Sumelahti, Marja-Liisa
Campos, Verena Ramirez
Ahn, Andrew H.
Lyras, Leonidas
Tassorelli, Cristina
CEPHALALGIA, 2023, 43 (11)
[8] Interim analyses of the multinational real-world prospective cohort HEM-POWR study evaluating the effectiveness and safety of damoctocog alfa pegol in patients with hemophilia A
Reding, Mark T.
Alvarez-Roman, Maria Teresa
Castaman, Giancarlo
Janbain, Maissaa
Matsushita, Tadashi
Meijer, Karina
Schmidt, Kathrin
Oldenburg, Johannes
EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (02) : 286 - 295
[9] Safety and effectiveness of insulin therapy in Chinese patients with type 2 diabetes mellitus: findings from the real-world SEAS study
Mu, Yi-Ming
Diao, Jian-Hua
Xu, Feng-Mei
Zhang, Yong-Ming
Liao, Lin
Wang, Min-Zhe
Zhang, Jing-Yi
Xu, Chun
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (08): : 16252 - 16262
[10] Effectiveness of Ixekizumab in Chinese Patients with Moderate-Severe Plaque Psoriasis with Special Area Involvement: Subanalysis of a Prospective, Multicenter, Observational Real-World Study
Li, Ying
Lv, Chengzhi
Dang, Lin
Lin, Bingjiang
Tao, Juan
Zhang, Chunlei
Zhou, Xiaoyong
Ma, Han
Lu, Yi
Chen, Rong
Li, Jinnan
Dou, Guanshen
Liang, Yunsheng
Liang, Yanhua
Shi, Yuling
DERMATOLOGY AND THERAPY, 2024, 14 (04) : 907 - 918

← 1 2 →